Xudong Zhu

Dr. Xudong Zhu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2020 in Postdigital Science and Education
Verified
Journal Article
Open access
PDF file
XZXudong Zhu
Xudong Zhu
JLJing Liu
Jing Liu

15 January 2025 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZGZhaoming Guo
Zhaoming Guo
YZYi Zhang
Yi Zhang
YGYuwei Gong
Yuwei Gong
GLGuqing Li
Guqing Li
JPJiawei Pan
Jiawei Pan
XZXudong Zhu
Xudong Zhu

17 July 2019 in Teachers and Teaching: Theory and Practice
Verified
Journal Article
Closed access
JYJuyan YE
Juyan YE
XZXudong Zhu
Xudong Zhu
LLLeslie N. K. Lo
Leslie N. K. Lo
This paper adopts an inductive analytical approach to reviewing the major state policies to reform teacher education in China. Based on the perceived impact on teachers and teacher education, 21 policy documents have been selected for this review. Five themes emerge in the analysis, which include: Expansion of teacher education by institutional diversification; structural changes through upgrading, merging and eliminating institutions and school; innovations on modes of teacher preparation, curricula and teaching practicum; certification and examinations; and strengthening teacher supply for the rural schools. The paper also analyses the contextual and systemic factors that affect the formulation and implementation of reform policies in teacher education and critically reflect the effect of these policies on Chinese teacher education.

1 January 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ZGZhaoming Guo
Zhaoming Guo
GLGuqing Li
Guqing Li
LSLanjun Shen
Lanjun Shen
JPJiawei Pan
Jiawei Pan
DDDanni Dou
Danni Dou
XZXudong Zhu
Xudong Zhu
Purpose: Phototherapy has remarkable advantages in cancer treatment, owing to its high efficiency and minimal invasiveness. Indocyanine green (ICG) plays an important role in photo-mediated therapy. However, it has several disadvantages such as poor stability in aqueous solutions, easy aggregation of molecules, and short plasma half-life. This study aimed to develop an efficient nanoplatform to enhance the effects of photo-mediated therapy. Methods: We developed a novel bio-nanoplatform by integrating edible ginger-derived exosome-like nanoparticles (GDNPs) and the photosensitizer, ICG (GDNPs@ICG). GDNPs were isolated from ginger juice and loaded with ICG by co-incubation. The size distribution, zeta potential, morphology, total lipid content, and drug release behavior of the GDNPs@ICG were characterized. The photothermal performance, cellular uptake and distribution, cytotoxicity, anti-tumor effects, and mechanism of action of GDNPs@ICG were investigated both in vitro and in vivo. Results: GDNPs@ICG were taken up by tumor cells via a lipid-dependent pathway. When irradiated by an 808 nm NIR laser, GDNPs@ICG generated high levels of ROS, MDA, and local hyperthermia within the tumor, which caused lipid peroxidation and ER stress, thus enhancing the photo-mediated breast tumor therapy effect. Furthermore, in vivo studies demonstrated that engineered GDNPs@ICG significantly inhibited breast tumor growth and presented limited toxicity. Moreover, by detecting the expression of CD31, N-cadherin, IL-6, IFN-γ, CD8, p16, p21, and p53 in tumor tissues, we found that GDNPs@ICG substantially reduced angiogenesis, inhibited metastasis, activated the anti-tumor immune response, and promoted cell senescence in breast tumor. Conclusion: Our study demonstrated that the novel bio-nanoplatform GDNPs@ICG enhanced the photo-mediated therapeutic effect in breast tumor. GDNPs@ICG could be an alternative for precise and efficient anti-tumor phototherapy.

26 October 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CCCheng Chen
Cheng Chen
YTYuanyang Tang
Yuanyang Tang
XZXudong Zhu
Xudong Zhu
JYJiacai Yang
Jiacai Yang
ZLZhihui Liu
Zhihui Liu
WHWeifeng He
Weifeng He

27 October 2024 in Clinical and Translational Medicine
Verified
Journal Article
Open access
LSLin Su
Lin Su
JBJiawen Bu
Jiawen Bu
JYJiahui Yu
Jiahui Yu
MJMila Jin
Mila Jin
GMGuanliang Meng
Guanliang Meng
XZXudong Zhu
Xudong Zhu
Hepatocellular carcinoma (HCC) is a primary malignant tumour, ranking second in global mortality rates and posing significant health threats. Epigenetic alterations, particularly DNA methylation, have emerged as pivotal factors associated with HCC diagnosis, therapy, prognosis and malignant progression. However, a comprehensive analysis of the DNA methylation mechanism driving HCC progression and its potential as a therapeutic biomarker remains lacking. This review attempts to comprehensively summarise various aspects of DNA methylation, such as its mechanism, detection methods and biomarkers aiding in HCC diagnosis, treatment and prognostic assessment of HCC. It also explores the role of DNA methylation in regulating HCC's malignant progression and sorafenib resistance, alongside elaborating the therapeutic effects of DNA methyltransferase inhibitors on HCC. A detailed examination of these aspects underscores the significant research on DNA methylation in tumour cells to elucidate malignant progression mechanisms, identify diagnostic markers and develop new tumour‐specific inhibitors for HCC.Key points: A comprehensive summary of various aspects of DNA methylation, such as its mechanism, detection methods and biomarkers aiding in diagnosis and treatment. The role of DNA methylation in regulating hepatocellular carcinoma's (HCC) malignant progression and sorafenib resistance, alongside elaborating therapeutic effects of DNA methyltransferase inhibitors. Deep research on DNA methylation is critical for discovering novel tumour‐specific inhibitors for HCC.